期刊文献+

体质指数联合卵泡输出率对女性不孕症患者经辅助生殖治疗后妊娠结局的预测价值 被引量:6

原文传递
导出
摘要 目的探讨体质指数(BMI)联合卵泡输出率(FORT)对女性不孕症患者经辅助生殖治疗后妊娠结局的预测价值。方法 106例行辅助生殖治疗的女性不孕症患者。根据FORT水平分为高FORT组、中FORT组、低FORT组;根据BMI值分为正常组与超重组。对各组的临床及实验室参数、妊娠结局进行对比分析。结果三组的生化妊娠、OHSS、中期流产、多胎妊娠、异位妊娠发生率比较,差异均无统计学意义(P>0.05);三组的临床妊娠率有高FORT组>中FORT组>低FORT组,早期流产率有高FORT组<中FORT组<低FORT组(P <0.05)。超重组的Gn时间显著短于正常组,Gn总量、PFC个数、获卵数分别均显著低于对照组(P <0.05)。超重组的临床妊娠率显著低于正常组(P <0.05)。FORT与临床妊娠呈正相关,BMI与临床妊娠呈负相关(P <0.05)。结论 FORT和BMI均与辅助生殖治疗后妊娠结局有关,二者可预测卵巢反应性及胚胎发育潜能。
出处 《中国妇产科临床杂志》 CSCD 2021年第3期321-322,共2页 Chinese Journal of Clinical Obstetrics and Gynecology
  • 相关文献

参考文献5

二级参考文献40

  • 1孙莹璞,刘美霞,苏迎春,郭艺红.经阴道彩色超声监测卵巢血流动力学变化评价IVF-ET中卵巢反应性和结局[J].生殖与避孕,2005,25(11):679-682. 被引量:8
  • 2ZawadsjuJK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach[M]. In: Dunaif A, GivenJR, Haseltine FP, eds. Polycystic ovary syndrome. Boston ( MA ) : Blackwell Scientific Publication, 1992,377-384.
  • 3Rotterdam ESHREI ASRM -Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome ( PCOS)[J]. Hum Reprod, 2004,19 :4147.
  • 4Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline[J].J Clin Endocrinol Metab, 2006, 91 :42374245.
  • 5Azziz R, Carmina E, Dewailly D, et al. Task Force on the Phenotype of the Polycystic Ovary Syndrome of the Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report[J]. Fertil Steril, 2009,91 :456488.
  • 6Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients[J].J Clin Endocrinol Metab, 2004,89:453462.
  • 7Lowenstein EJ. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome[J]. Dermatol Ther, 2006,19:210-223.
  • 8Arias-Santiago S, Cutierrez-Salmeron MT, Castellote-Caballero L, et al. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study[J].JAm Acad Dermatol, 2010 ,63 :420- 429.
  • 9Matilainen V, Laakso M, Hirsso P, et al. Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study[J]. Lancet, 2000,356:1165-1166.
  • 10Azziz R, Ehrmann D, Legro RS, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial[J].J Clin Endocrinol Metab, 2001 , 86: 1626-1632.

共引文献228

同被引文献60

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部